Functional Characterization of Mouse and Human Arachidonic Acid Lipoxygenase 15B (ALOX15B) Orthologs and of Their Mutants Exhibiting Humanized and Murinized Reaction Specificities.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Jun 2023
Historique:
received: 16 03 2023
revised: 06 06 2023
accepted: 08 06 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

The arachidonic acid lipoxygenase 15B (ALOX15B) orthologs of men and mice form different reaction products when arachidonic acid is used as the substrate. Tyr603Asp+His604Val double mutation in mouse arachidonic acid lipoxygenase 15b humanized the product pattern and an inverse mutagenesis strategy murinized the specificity of the human enzyme. As the mechanistic basis for these functional differences, an inverse substrate binding at the active site of the enzymes has been suggested, but experimental proof for this hypothesis is still pending. Here we expressed wildtype mouse and human arachidonic acid lipoxygenase 15B orthologs as well as their humanized and murinized double mutants as recombinant proteins and analyzed the product patterns of these enzymes with different polyenoic fatty acids. In addition, in silico substrate docking studies and molecular dynamics simulation were performed to explore the mechanistic basis for the distinct reaction specificities of the different enzyme variants. Wildtype human arachidonic acid lipoxygenase 15B converted arachidonic acid and eicosapentaenoic acid to their 15-hydroperoxy derivatives but the Asp602Tyr+Val603His exchange murinized the product pattern. The inverse mutagenesis strategy in mouse arachidonic acid lipoxygenase 15b (Tyr603Asp+His604Val exchange) humanized the product pattern with these substrates, but the situation was different with docosahexaenoic acid. Here, Tyr603Asp+His604Val substitution in mouse arachidonic acid lipoxygenase 15b also humanized the specificity but the inverse mutagenesis (Asp602Tyr+Val603His) did not murinize the human enzyme. With linoleic acid Tyr603Asp+His604Val substitution in mouse arachidonic acid lipoxygenase 15b humanized the product pattern but the inverse mutagenesis in human arachidonic acid lipoxygenase 15B induced racemic product formation. Amino acid exchanges at critical positions of human and mouse arachidonic acid lipoxygenase 15B orthologs humanized/murinized the product pattern with C20 fatty acids, but this was not the case with fatty acid substrates of different chain lengths. Asp602Tyr+Val603His exchange murinized the product pattern of human arachidonic acid lipoxygenase 15B with arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid. An inverse mutagenesis strategy on mouse arachidonic acid lipoxygenase 15b (Tyr603Asp+His604Val exchange) did humanize the reaction products with arachidonic acid and eicosapentaenoic acid, but not with docosahexaenoic acid.

Identifiants

pubmed: 37373195
pii: ijms241210046
doi: 10.3390/ijms241210046
pmc: PMC10298594
pii:
doi:

Substances chimiques

Arachidonate Lipoxygenases EC 1.13.11.-
Eicosapentaenoic Acid AAN7QOV9EA
Docosahexaenoic Acids 25167-62-8
Arachidonic Acid 27YG812J1I
Fatty Acids 0
Arachidonate 15-Lipoxygenase EC 1.13.11.33

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministerio de Ciencia e Innovación
ID : PID2020-113764GB-I00

Références

J Chem Inf Model. 2016 Apr 25;56(4):599-604
pubmed: 26913476
Biophys Chem. 2022 Sep;288:106855
pubmed: 35849958
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6148-52
pubmed: 9177185
J Lipid Res. 1994 Oct;35(10):1749-59
pubmed: 7852852
Prog Lipid Res. 2018 Oct;72:55-74
pubmed: 30237084
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Feb;1863(2):152-164
pubmed: 29146531
Adv Immunol. 2019;142:65-84
pubmed: 31296303
J Biol Chem. 1996 Sep 20;271(38):23338-44
pubmed: 8798535
Biochim Biophys Acta. 2006 Mar;1761(3):292-300
pubmed: 16647293
Methods Mol Biol. 2018;1835:69-105
pubmed: 30109646
J Phys Chem Lett. 2014 Nov 6;5(21):3863-3871
pubmed: 25400877
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Jul;1862(7):666-675
pubmed: 28400162
Atherosclerosis. 2012 Nov;225(1):121-7
pubmed: 22980500
J Biol Chem. 1997 Sep 26;272(39):24410-6
pubmed: 9305900
J Chem Theory Comput. 2016 Apr 12;12(4):2079-90
pubmed: 26918937
Biochim Biophys Acta. 1989 Feb 20;1001(3):274-81
pubmed: 2492826
J Chem Theory Comput. 2020 Jan 14;16(1):528-552
pubmed: 31714766
J Mol Biol. 1997 Apr 4;267(3):727-48
pubmed: 9126849
Front Pharmacol. 2022 Nov 09;13:1042420
pubmed: 36438817
Eur J Biochem. 1993 Apr 1;213(1):251-61
pubmed: 8477699
Biochemistry. 2009 Sep 15;48(36):8721-30
pubmed: 19645454
FEBS Lett. 1975 Dec 1;60(1):149-52
pubmed: 6318
Proteins. 2003 Sep 1;52(4):609-23
pubmed: 12910460
Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:303-12
pubmed: 12432925
J Biol Chem. 1990 Oct 25;265(30):18351-61
pubmed: 2120232
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444
pubmed: 34791371
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Chem Rev. 2011 Oct 12;111(10):5866-98
pubmed: 21936577
FEBS J. 2022 Jul;289(14):4212-4227
pubmed: 34741578
Free Radic Biol Med. 2022 Jul;187:113-122
pubmed: 35580774
Front Pharmacol. 2022 Mar 02;13:838782
pubmed: 35308198
J Chem Inf Model. 2017 Jul 24;57(7):1511-1516
pubmed: 28594549
Biochim Biophys Acta. 2009 Aug;1791(8):827-35
pubmed: 19481615
J Biol Chem. 2000 Jan 14;275(2):1287-93
pubmed: 10625675
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158702
pubmed: 32222425
J Biol Chem. 1991 Aug 25;266(24):15738-45
pubmed: 1874732
Microbiologyopen. 2019 Jul;8(7):e00775
pubmed: 30560563
J Biol Chem. 2016 Sep 9;291(37):19413-24
pubmed: 27435673
FEBS J. 2021 Feb;288(4):1387-1406
pubmed: 32627384
Biomedicines. 2022 Jun 10;10(6):
pubmed: 35740398
J Biol Chem. 2014 Mar 21;289(12):8562-9
pubmed: 24497644
Biochemistry. 2008 Jul 15;47(28):7364-75
pubmed: 18570379
Chem Phys Lipids. 2019 Mar;219:45-49
pubmed: 30707909
Biochim Biophys Acta. 2015 Apr;1851(4):308-30
pubmed: 25316652

Auteurs

Kumar R Kakularam (KR)

Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, D-10117 Berlin, Germany.

Miquel Canyelles-Niño (M)

Departament de Química, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Arquebio S.L., 08005 Barcelona, Spain.

Xin Chen (X)

Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, D-10117 Berlin, Germany.

José M Lluch (JM)

Departament de Química, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Institut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.

Àngels González-Lafont (À)

Departament de Química, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Institut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.

Hartmut Kuhn (H)

Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, D-10117 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH